[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Aims and Scope
Content Coverage
Conflict of Interest
Publication Ethics
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Current Issue
All Issues
Indexing Databases::
Contact Us::
Contact Us
Contact Form
Site Facilities::
Search contents
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 19, Issue 3 (10-2017) ::
J Gorgan Univ Med Sci 2017, 19(3): 32-37 Back to browse issues page
Increased risk of gastric cancer in the CC genotype -31C/G polymorphism in Survivin gene promoter
Z Bagheri1 , P Mohamadynejad * 2, M Moghanibashi3
1- M.Sc in Genetics, Department of Biology, Faculty of Basic Sciences, Sharekord Branch, Islamic Azad University, Shahrekord, Iran
2- Ph.D in Genetics, Assistant Professor, Department of Biology, Faculty of Basic Sciences, Sharekord Branch, Islamic Azad University, Shahrekord, Iran , parisamohamadynejad@yahoo.com
3- Ph.D in Genetics, Assistant Professor, Department of Genetic, School of Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Shiraz, Iran
Abstract:   (9345 Views)
Background and Objective: Gastric cancer is the most common cancers worldwide. The survivin gene which encodes an apoptosis protein inhibitor plays an important role in maintenance and integrity of the gastric mucosa. The gene is necessary for the normal physiologic function of the stomach, but its expression increases in gastric cancer. Regarding with the role of polymorphisms of the promoter region in genes expression, this study was done to determine the association of single- nucleotide polymorphism (rs9904341) -31C/G in promoter survivin gene with risk of gastric cancers.
Methods: In this case-control study, 101 patients with gastric cancer and 101 matched age and gender healthy subjects as the control were examined by PCR-RFLP technique.
Results: Genotype CC was significantly increased the risk of gastric cancer up to 2.4 folds (95% CI=1.03–5.61, P<0.04) and allele C, as risk allele, significantly increased the risk of gastric cancer up to 1.5 folds (95% CI=1.02–2.30, P<0.03). Also, CC + GC genotypes significantly increased the risk of diffuse type of gastric cancer by 4.4-fold (95% CI=1.30-15.10, OR=4.4, P<0.01).
Conclusion: This study showed that single- nucleotide polymorphism (rs9904341) -31C/G in promoter survivin gene significantly increase the risk of gastric cancers.
Keywords: Gastric cancer, Survivin gene, Single nucleotide polymorphism- rs9904341
Full-Text [PDF 257 kb] [English Abstract]   (15815 Downloads) |   |   Abstract (HTML)  (1061 Views)  
Type of Study: Original Articles | Subject: Genetic
References
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006 Mar-Apr; 56(2): 106-30.
2. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009 Nov; 12(6): 576-83.
3. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004 Jan; 57(1): 37-42.
4. Wu MS, Chen CJ, Lin JT. Host–environment interactions: their impact on progression from gastric inflammation to carcinogenesis and ondevelopment of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(8): 1878-82.
5. Kamangar F, Sheikhattari P, Mohebtash M. Helicobacter pylori and its effects on human health and disease. Arch Iran Med. 2011 May; 14(3): 192-99. doi:011143/AIM.0010
6. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007 Jun; 165(12): 1424-33.
7. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991 May; 83(9): 640-43.
8. Kwon SJ. Evaluation of the seventh UICC TNM Staging System of Gastric Cancer. J Gastric Cancer. 2011; 11(2): 78-85. doi:10.5230/jgc.2011.11.2.78
9. Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, Papaconstantinou I, Kostakis A, et al. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis. 2009 Feb; 24(2): 145-50. doi:10.1007/s00384-008-0601-2
10. Deveraux QL, Reed JC. IAP family proteins--suppressors of apoptosis. Genes Dev. 1999 Feb; 13(3): 239-52.
11. Borbe´ly AA, Murvai M, Szarka K, Ko´nya J, Gergely L, Veress G. Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol. 2007; 60(3): 303-36. doi:10.1136/jcp.2006.037804
12. Wenzel M, Mahotka C, Krieg A, Bachmann A, Schmitt M, Gabbert HE, et al. Novel survivin-related members of the inhibitor of apoptosis (IAP) family. Cell Death and Differentiation. 2000; 7(7): 682-83.
13. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998 Dec; 58(23): 5315-20.
14. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998 Dec; 396(6711): 580-84.
15. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med. 2001 Dec; 7(12): 542-47.
16. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997 Aug; 3(8): 917-21.
17. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, et al. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci. 2009 May; 54(5): 1021-28. doi:10.1007/s10620-008-0441-5
18. Chiou SK, Moon WS, Jones MK, Tarnawski AS. Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun. 2003 May; 305(2): 374-79.
19. GuhaThakurta D, Xie T, Anand M, Edwards SW, Li G, Wang SS, Schadt EE. Cis-regulatory variations: a study of SNPs around genes showing cis-linkage in segregating mouse populations. BMC Genomics. 2006 Sep; 7: 235. doi:10.1186/1471-2164-7-235
20. Wang X, Tomso DJ, Liu X, Bell DA. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol. 2005 Sep; 207(2 Suppl): 84-90. doi:10.1016/j.taap.2004.09.024
21. Kim BC, Kim WY, Park D, Chung WH, Shin KS, Bhak J. SNP@Promoter: a database of human SNPs (single nucleotide polymorphisms) within the putative promoter regions. BMC Bioinformatics. 2008; 9 (Suppl 1): S2. doi:10.1186/1471-2105-9-S1-S2
22. Han CH, Wei Q, Lu KK, Liu Z, Mills GB, Wang LE. Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. Int J Clin Exp Med. 2009 Oct; 2(4): 289-99.
23. Borges BN, Burbano RR, Harada ML. Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med. 2011 Sep; 11(3): 189-93. doi:10.1007/s10238-010-0122-5
24. Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, et al. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer. 2011 Oct; 129(8): 1872-80. doi:10.1002/ijc.25850
25. Lauren P. The two histological main types of gastric carcinoma:diffuse and so-called intestinal-type carcinoma. an attempt at ahisto-clinical classification. Acta Pathol Microbiol Scand. 1965; 64: 31-49.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb; 16(3): 1215.
27. Wang X, Huang L, Xu Y, Shi Zh, Wang Y, Zhang J, et al. Association between survivin -31G/C promoter polymorphism and cancer risk: a meta-analysis. European Journal of Human Genetics. 2012; 20: 790-95.
28. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis. 2002 Feb; 23(2): 257-64.
29. Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis. 2006 Dec; 27(12): 2491-96. doi:10.1093/carcin/bgl121
Send email to the article author

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bagheri Z, Mohamadynejad P, Moghanibashi M. Increased risk of gastric cancer in the CC genotype -31C/G polymorphism in Survivin gene promoter. J Gorgan Univ Med Sci 2017; 19 (3) :32-37
URL: http://goums.ac.ir/journal/article-1-3134-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 3 (10-2017) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 35 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)